Securities and Exchange Commission
SEC v. Sumit Rai
PendingFiled: January 14, 2026
Sumit Rai allegedly made misrepresentations to investors and misappropriated at least $10.6 million in investor funds, according to the SEC. Kim deMora was charged with aiding and abetting the alleged fraud. Relief Defendant Cancer Check is alleged to have received ill-gotten gains in connection with the fraudulent scheme.
Summary generated from official Securities and Exchange Commission press release
Source: Securities and Exchange Commission Press Release ↗Parties
Defendants / Respondents
- Sumit Rai
- SVN Med LLC
- NVS Med Inc.
- Onco Filtration, Inc.
- Kim deMora
- Cancer Check Labs, LLC
Dates
Filed
January 14, 2026
Published
January 15, 2026
Case Details
Industry
Finance